118 related articles for article (PubMed ID: 7999264)
21. Functional expression of fused enzymes between human cytochrome P4501A1 and human NADPH-cytochrome P450 oxidoreductase in Saccharomyces cerevisiae.
Wittekindt NE; Würgler FE; Sengstag C
DNA Cell Biol; 1995 Apr; 14(4):273-83. PubMed ID: 7710684
[TBL] [Abstract][Full Text] [Related]
22. Modulation of aflatoxin B1 biotransformation in rabbit pulmonary and hepatic microsomes.
Daniels JM; Massey TE
Toxicology; 1992 Aug; 74(1):19-32. PubMed ID: 1514185
[TBL] [Abstract][Full Text] [Related]
23. Functional co-expression of human oxidoreductase and cytochrome P450 1A1 in Saccharomyces cerevisiae results in increased EROD activity.
Eugster HP; Bärtsch S; Würgler FE; Sengstag C
Biochem Biophys Res Commun; 1992 Jun; 185(2):641-7. PubMed ID: 1610357
[TBL] [Abstract][Full Text] [Related]
24. Expression of human cytochromes P450 1A1 and P450 1A2 as fused enzymes with yeast NADPH-cytochrome P450 oxidoreductase in transgenic tobacco plants.
Shiota N; Kodama S; Inui H; Ohkawa H
Biosci Biotechnol Biochem; 2000 Oct; 64(10):2025-33. PubMed ID: 11129571
[TBL] [Abstract][Full Text] [Related]
25. Xenobiotic metabolism in humanized yeast: engineered yeast cells producing human NADPH-cytochrome P-450 reductase, cytochrome b5, epoxide hydrolase and P-450s.
Urban P; Truan G; Gautier JC; Pompon D
Biochem Soc Trans; 1993 Nov; 21(4):1028-34. PubMed ID: 8131892
[No Abstract] [Full Text] [Related]
26. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase.
Fujita K; Kamataki T
Mutat Res; 2001 Nov; 483(1-2):35-41. PubMed ID: 11600130
[TBL] [Abstract][Full Text] [Related]
27. Expression of a human cytochrome p450 in yeast permits analysis of pathways for response to and repair of aflatoxin-induced DNA damage.
Guo Y; Breeden LL; Zarbl H; Preston BD; Eaton DL
Mol Cell Biol; 2005 Jul; 25(14):5823-33. PubMed ID: 15988000
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of human cytochrome P450 1B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin.
Takahashi E; Fujita K; Kamataki T; Arimoto-Kobayashi S; Okamoto K; Negishi T
Mutat Res; 2002 Oct; 508(1-2):147-56. PubMed ID: 12379470
[TBL] [Abstract][Full Text] [Related]
29. Liver carcinogen aflatoxin B1 as an inducer of mitotic recombination in a human cell line.
Stettler PM; Sengstag C
Mol Carcinog; 2001 Jul; 31(3):125-38. PubMed ID: 11479921
[TBL] [Abstract][Full Text] [Related]
30. Effects of various inducers on the activities of cytochrome P-450-mixed function oxidases and aflatoxin B1 activation in microsomes of hamster livers.
Sunouchi M; Fukuhara M; Ohno Y; Takanaka A
J Toxicol Sci; 1988 Nov; 13(4):193-204. PubMed ID: 3149679
[TBL] [Abstract][Full Text] [Related]
31. Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens.
Kranendonk M; Mesquita P; Laires A; Vermeulen NP; Rueff J
Mutagenesis; 1998 May; 13(3):263-9. PubMed ID: 9643585
[TBL] [Abstract][Full Text] [Related]
32. Aflatoxin B1-induced mitotic recombination in L5178Y mouse lymphoma cells.
Preisler V; Caspary WJ; Hoppe F; Hagen R; Stopper H
Mutagenesis; 2000 Jan; 15(1):91-7. PubMed ID: 10640536
[TBL] [Abstract][Full Text] [Related]
33. Cytogenetic effects of promutagens in genetically engineered V79 Chinese hamster cells expressing cytochromes P450.
Kulka U; Doehmer J; Glatt HR; Bauchinger M
Eur J Pharmacol; 1993 Apr; 228(5-6):299-304. PubMed ID: 8482321
[TBL] [Abstract][Full Text] [Related]
34. Engineered yeast cells as model to study coupling between human xenobiotic metabolizing enzymes. Simulation of the two first steps of benzo[a]pyrene activation.
Gautier JC; Urban P; Beaune P; Pompon D
Eur J Biochem; 1993 Jan; 211(1-2):63-72. PubMed ID: 8425552
[TBL] [Abstract][Full Text] [Related]
35. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
[TBL] [Abstract][Full Text] [Related]
36. Cytochrome P450 forms in the rodent lung involved in the metabolic activation of food-derived heterocyclic amines.
Hellmold H; Overvik E; Strömstedt M; Gustafsson JA
Carcinogenesis; 1993 Sep; 14(9):1751-7. PubMed ID: 8403195
[TBL] [Abstract][Full Text] [Related]
37. An in vitro system for measuring genotoxicity mediated by human CYP3A4 in Saccharomyces cerevisiae.
Fasullo M; Freedland J; St John N; Cera C; Egner P; Hartog M; Ding X
Environ Mol Mutagen; 2017 May; 58(4):217-227. PubMed ID: 28436563
[TBL] [Abstract][Full Text] [Related]
38. In vitro cytochrome P450 monooxygenase and prostaglandin H-synthase mediated aflatoxin B1 biotransformation in guinea pig tissues: effects of beta-naphthoflavone treatment.
Liu L; Nakatsu K; Massey TE
Arch Toxicol; 1993; 67(6):379-85. PubMed ID: 8215906
[TBL] [Abstract][Full Text] [Related]
39. Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice.
Arlt VM; Stiborová M; Henderson CJ; Thiemann M; Frei E; Aimová D; Singh R; Gamboa da Costa G; Schmitz OJ; Farmer PB; Wolf CR; Phillips DH
Carcinogenesis; 2008 Mar; 29(3):656-65. PubMed ID: 18204078
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds.
Shimada T; El-Bayoumy K; Upadhyaya P; Sutter TR; Guengerich FP; Yamazaki H
Cancer Res; 1997 Nov; 57(21):4757-64. PubMed ID: 9354437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
